Brain PET in Suspected Dementia: Patterns of Altered FDG Metabolism
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
The diagnosis of dementia syndromes can be challenging for clinicians, particularly in the early stages of disease. Patients with higher education levels may experience a marked decline in cognitive function before their dementia is detectable with routine testing methods. In addition, comorbid conditions (eg, depression) and the use of certain medications can confound the clinical assessment. Clinicians require a high degree of certainty before making a diagnosis of Alzheimer disease or some other neurodegenerative disorder, since the impact on patients and their families can be devastating. Moreover, accurate diagnosis is important because emerging therapeutic regimens vary depending on the cause of the dementia. Clinically based testing is useful; however, the results usually do not enable the clinician to make a definitive diagnosis. For this reason, imaging biomarkers are playing an increasingly important role in the workup of patients with suspected dementia. Positron emission tomography with 2-[fluorine-18]fluoro-2-deoxy-D-glucose allows detection of neurodegenerative disorders earlier than is otherwise possible. Accurate interpretation of these studies requires recognition of typical metabolic patterns caused by dementias and of artifacts introduced by image processing. Although visual interpretation is a vital component of image analysis, computer-assisted diagnostic software has been shown to increase diagnostic accuracy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, sMRI and (18FDG)-PET indicate neurodegeneration or neuronal injury in the AT(N) framework with limitations in specifically diagnosing AD.”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [369]
In the citing paper
“They cannot accurately differentiate AD from other neurodegenerative diseases with similar pathologies, such as frontotemporal degeneration and TDP-43 proteinopathies with medial temporal lobe atrophy.”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [369]
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420114 · Cited by 1,802
Self-citationMosconi, L., Tsui, W. H., Herholz, K., Pupi, A., Drzezga, A., Lucignani, G., Reiman, E. M., Holthoff, V., Kalbe, E., Sorbi, S., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045385 · Cited by 726
Self-citationFDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease
Foster, N. L., Heidebrink, J. L., Clark, C. M., Jagust, W. J., Arnold, S. E., Barbas, N. R., DeCarli, C. S., Scott Turner, R., Koeppe, R. A., Higdon, R., et al. (2007) · Brain · doi:10.1093/brain/awm177 · Cited by 608
Self-citationFocal cortical presentations of Alzheimer's disease
Alladi, S., Xuereb, J., Bak, T., Nestor, P., Knibb, J., Patterson, K., & Hodges, J. R. (2007) · Brain · doi:10.1093/brain/awm213 · Cited by 581
White matter lesions impair frontal lobe function regardless of their location
Tullberg, M., Fletcher, E., DeCarli, C., Mungas, D., Reed, B. R., Harvey, D. J., Weiner, M. W., Chui, H. C., & Jagust, W. J. (2004) · Neurology · doi:10.1212/01.wnl.0000130530.55104.b5 · Cited by 530
Black, S., Gao, F., & Bilbao, J. (2009) · Stroke · doi:10.1161/strokeaha.108.537704 · Cited by 379
Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease
Chetelat, G., Desgranges, B., Landeau, B., Mezenge, F., Poline, J. B., de la Sayette, V., Viader, F., Eustache, F., & Baron, J.-C. (2007) · Brain · doi:10.1093/brain/awm288 · Cited by 339
What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?
Jagust, W., Reed, B., Mungas, D., Ellis, W., & DeCarli, C. (2007) · Neurology · doi:10.1212/01.wnl.0000269790.05105.16 · Cited by 298
Positron emission tomography imaging in dementia
HERHOLZ, K., CARTER, S. F., & JONES, M. (2007) · The British Journal of Radiology · doi:10.1259/bjr/97295129 · Cited by 287
Langbaum, J. B. S., Chen, K., Lee, W., Reschke, C., Bandy, D., Fleisher, A. S., Alexander, G. E., Foster, N. L., Weiner, M. W., Koeppe, R. A., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.12.072 · Cited by 279
Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment.
Dolan, R. J., Bench, C. J., Brown, R. G., Scott, L. C., Friston, K. J., & Frackowiak, R. S. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.9.768 · Cited by 244
Self-citationDiehl, J., Grimmer, T., Drzezga, A., Riemenschneider, M., Förstl, H., & Kurz, A. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.10.007 · Cited by 208
Glucose Hypometabolism and Neuropathological Correlates in Brains of Dementia with Lewy Bodies
Higuchi, M., Tashiro, M., Arai, H., Okamura, N., Hara, S., Higuchi, S., Itoh, M., Shin, R.-W., Trojanowski, J. Q., & Sasaki, H. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7342 · Cited by 206
Yuan, Y., Gu, Z.-X., & Wei, W.-S. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1357 · Cited by 206
Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study
Diehl-Schmid, J., Grimmer, T., Drzezga, A., Bornschein, S., Riemenschneider, M., Förstl, H., Schwaiger, M., & Kurz, A. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.11.002 · Cited by 199
(2005) · PubMed · Cited by 191
Meltzer, C. C., Zubieta, J. K., Brandt, J., Tune, L. E., Mayberg, H. S., & Frost, J. J. (1996) · Neurology · doi:10.1212/wnl.47.2.454 · Cited by 182
Imamura, T., Ishii, K., Sasaki, M., Kitagaki, H., Yamaji, S., Hirono, N., Shimomura, T., Hashimoto, M., Tanimukai, S., Kazui, H., et al. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00713-1 · Cited by 159
Yong, S. W., Yoon, J. K., An, Y. S., & Lee, P. H. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01977.x · Cited by 142
Sultzer, D. L. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540320049012 · Cited by 139
Yakushev, I. Y., Landvogt, C., Buchholz, H., Fellgiebel, A., Hammers, A., Scheurich, A., Schmidtmann, I. M., Gerhard, A., Schreckenberger, M., & Bartenstein, P. (2008) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2007.11.004 · Cited by 130
Baron, J., Lebrun-Grandie, P., Collard, P., Crouzel, C., Mestelan, G., & Bousser, M. (1982) · PubMed · Cited by 129
Morbelli, S. D., Piccardo, A., Villavecchia, G., Dessi, B., Brugnolo, A., Piccini, A., Caroli, A., Frisoni, G. B., Rodriguez, G., & Nobili, F. M. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1218-6 · Cited by 122
Kerrouche, N., Herholz, K., Mielke, R., Holthoff, V., & Baron, J.-C. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600296 · Cited by 120
Sole, A. D., Clerici, F., Chiti, A., Lecchi, M., Mariani, C. B., Maggiore, L., Mosconi, L., & Lucignani, G. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0773-6 · Cited by 117
Gilman, S., Koeppe, R. A., Little, R. J. A., An, H., Junck, L., Giordani, B., Persad, C. C., Heumann, M., & Wernette, K. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.06.017 · Cited by 112
Positron emission tomography for diagnosis of Alzheimer’s disease and vascular dementia
Mielke, R., & Heiss, W. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_21 · Cited by 105
Cerebral Metabolic Dysfunction in Patients with Dementia with Lewy Bodies and Visual Hallucinations
Perneczky, R., Drzezga, A., Boecker, H., Förstl, H., Kurz, A., & Häussermann, P. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000132084 · Cited by 103
Kanda, T., Ishii, K., Uemura, T., Miyamoto, N., Yoshikawa, T., Kono, A. K., & Mori, E. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0871-5 · Cited by 98
Imamura, T., Ishii, K., Hirono, N., Hashimoto, M., Tanimukai, S., Kazui, H., Hanihara, T., Sasaki, M., & Mori, E. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051257 · Cited by 91
MINOSHIMA, S., CROSS, D. J., FOSTER, N. L., HENRY, T. R., & KUHL, D. E. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07852.x · Cited by 90
Self-citationClinical application of positron emission tomography for diagnosis of dementia
Ishii, K. (2002) · Annals of Nuclear Medicine · doi:10.1007/bf02988628 · Cited by 79
Grimmer, T., Diehl, J., Drzezga, A., Förstl, H., & Kurz, A. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000077732 · Cited by 78
Ishii, K., Kono, A. K., Sasaki, H., Miyamoto, N., Fukuda, T., Sakamoto, S., & Mori, E. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-0015-0 · Cited by 76
Choo, I. H., Lee, D. Y., Youn, J. C., Jhoo, J. H., Kim, K. W., Lee, D. S., Lee, J. S., & Woo, J. I. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3180687418 · Cited by 68
Matsunari, I., Samuraki, M., Chen, W.-P., Yanase, D., Takeda, N., Ono, K., Yoshita, M., Matsuda, H., Yamada, M., & Kinuya, S. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.042820 · Cited by 67
Positron Emission Tomography Diagnosis of Alzheimer's Disease
Coleman, R. E. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.007 · Cited by 65
Kawasaki, K., Ishii, K., Saito, Y., Oda, K., Kimura, Y., & Ishiwata, K. (2008) · Annals of Nuclear Medicine · doi:10.1007/s12149-007-0099-7 · Cited by 64
Duara, R., Barker, W., Loewenstein, D., Pascal, S., & Bowen, B. (1989) · European Neurology · doi:10.1159/000116474 · Cited by 63
Contrasting metabolic impairment in frontotemporal degeneration and early onset Alzheimer's disease
Ibach, B., Poljansky, S., Marienhagen, J., Sommer, M., Männer, P., & Hajak, G. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.06.041 · Cited by 62
[18F]FDG-PET study in dementia with lewy bodies and alzheimer's disease
Okamura, N., Arai, H., Higuchi, M., Tashiro, M., Matsui, T., Hu, X.-S., Takeda, A., Itoh, M., & Sasaki, H. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)80005-1 · Cited by 59
Kono, A. K., Ishii, K., Sofue, K., Miyamoto, N., Sakamoto, S., & Mori, E. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0380-y · Cited by 59
Heertum, R. L. V., & Tikofsky, R. S. (2003) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2003.127294 · Cited by 56
Herholz, K. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211000937 · Cited by 56
Brain reserve capacity in frontotemporal dementia: a voxel-based 18F-FDG PET study
Perneczky, R., Diehl‐Schmid, J., Drzezga, A. E., & Kurz, A. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0323-z · Cited by 55
Foster, N. L., VanDerSpek, A. F. L., Aldrich, M. S., Berent, S., Hichwa, R. H., Sackellares, J. C., Gilman, S., & Agranoff, B. W. (1987) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1987.84 · Cited by 55
PET imaging in the assessment of normal and impaired cognitive function
Silverman, D. H. S., & Alavi, A. A. (2005) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2004.09.012 · Cited by 55
Buchert, R., Wilke, F., Chakrabarti, B., Martin, B., Brenner, W., Mester, J., & Clausen, M. (2005) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2005.tb00335.x · Cited by 54
Comparison of FDG-PET and IMP-SPECT in patients with dementia with Lewy bodies
Ishii, K., Hosaka, K., Mori, T., & Mori, E. (2004) · Annals of Nuclear Medicine · doi:10.1007/bf02984489 · Cited by 48
Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography
Burke, J. F., Albin, R. L., Koeppe, R. A., Giordani, B., Kilbourn, M. R., Gilman, S., & Frey, K. A. (2011) · Brain · doi:10.1093/brain/awr089 · Cited by 48
Self-citationKuczynski, B., Reed, B., Mungas, D., Weiner, M., Chui, H. C., & Jagust, W. (2008) · Archives of Neurology · doi:10.1001/archneur.65.5.650 · Cited by 46
Neuroimaging in Dementia with Lewy Bodies: Metabolism, Neurochemistry, and Morphology
Minoshima, S., Foster, N. L., Petrie, E. C., Albin, R. L., Frey, K. A., & Kuhl, D. E. (2002) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198870201500405 · Cited by 44
Self-citationMarkiewicz, P. J., Matthews, J. C., Declerck, J. M., & Herholz, K. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.01.020 · Cited by 44
Multiple pathologies are common in Alzheimer patients in clinical trials
Wang, B. W., Lu, E., Mackenzie, I. R. A., Assaly, M., Jacova, C., Lee, P. E., Beattie, B. L., & Hsiung, G. Y. R. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100015316 · Cited by 41
Functional Imaging in Parkinson’s Disease and Dementia with Lewy Bodies
Colloby, S. J., & O'Brien, J. T. (2004) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988704267468 · Cited by 41
Metabolic Correlates of Brain Reserve in Dementia with Lewy Bodies: An FDG PET Study
Perneczky, R., Häussermann, P., Diehl-Schmid, J., Boecker, H., Förstl, H., Drzezga, A., & Kurz, A. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000101956 · Cited by 37
One-Year Change in Cerebral Glucose Metabolism in Patients With Alzheimer's Disease
Hirono, N. (2004) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.16.4.488 · Cited by 34
Positron Emission Tomography Facilitates Diagnosis of Early-Onset Alzheimer’s Disease
McMurtray, A. M., Licht, E., Yeo, T., Krisztal, E., Saul, R. E., & Mendez, M. F. (2008) · European Neurology · doi:10.1159/000109258 · Cited by 33
Hosaka, K., Ishii, K., Sakamoto, S., Sadato, N., Fukuda, H., Kato, T., Sugimura, K., & Senda, M. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1576-z · Cited by 33
Foster, N. L., Wang, A. Y., Taşdizen, T., Fletcher, P. T., Hoffman, J. M., & Koeppe, R. A. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.10.004 · Cited by 32
Perneczky, R., Häussermann, P., Drzezga, A. E., Boecker, H., Granert, O., Feurer, R., Förstl, H., & Kurz, A. (2009) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181961a6f · Cited by 31
Arlt, S., Brassen, S., Jahn, H., Wilke, F., Eichenlaub, M., Apostolova, I. I., Wenzel, F., Thiele, F. O., Young, S., & Buchert, R. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1063-7 · Cited by 30
Dementia With Lewy Bodies Studied With Positron Emission Tomography
Cordery, R. J., Tyrrell, P. J., Lantos, P. L., & Rossor, M. N. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.505 · Cited by 27
Gallucci, M., Limbucci, N., Catalucci, A., & Caulo, M. (2008) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2008.06.002 · Cited by 25
Cerebral metabolic patterns in untreated postmenopausal women with major depressive disorder
Rasgon, N., Kenna, H. A., Geist, C. L., Small, G. W., & Silverman, D. H. S. (2008) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2007.12.006 · Cited by 23
Validating FDG-PET as a biomarker for frontotemporal dementia
Foster, N. L. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00360-1 · Cited by 21
Zahn, R., Garrard, P., Talazko, J., Gondan, M., Bubrowski, P., Juengling, F. D., Slawik, H. C., Dykierek, P., Koester, B., & Hüll, M. (2006) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2006.18.12.2138 · Cited by 20
Verification of predicted robustness and accuracy of multivariate analysis
Markiewicz, P. J., Matthews, J. C., Declerck, J. M., & Herholz, K. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.02.036 · Cited by 18
Doyle, C. A., & Slater, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12196-x · Cited by 18
Brain Metabolic Correlates of Cerebrospinal Fluid Beta-Amyloid 42 and Tau in Alzheimer’s Disease
Vukovich, R., Perneczky, R., Drzezga, A. E., Förstl, H., Kurz, A., & Riemenschneider, M. J. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000218080 · Cited by 18
Potential Value of Quantitative Analysis of Cerebral PET in Early Cognitive Decline
Patterson, J. C., Lilien, D. L., Takalkar, A. M., Kelley, R. E., & Minagar, A. (2008) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317508323447 · Cited by 10
Decreased cerebral glucose metabolism associated with mental deterioration in multi-infarct dementia
Meguro, K., Doi, C., Ueda, M., Yamaguchi, T., Matsui, H., Kinomura, S., Itoh, M., Yamada, K., & Sasaki, H. (1991) · Neuroradiology · doi:10.1007/bf00587811 · Cited by 9
Kotagal, V., Lorincz, M. T., & Bohnen, N. I. (2012) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e31824440a1 · Cited by 8
Self-citationIs positron emission tomography useful in stroke?
Reuck, J. D., Leys, D., & Keyser, J. D. (1997) · PubMed · Cited by 8
Tanaka, M., Okamoto, K., & Hirai, S. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04808.x · Cited by 5
Research works printed but not linked: 3
- Jeong Y, 2005, J Nucl Med, 46, 233
- De Reuck J, 1997, Acta Neurol Belg, 97, 168
- Baron JC, 1982, J Nucl Med, 23, 391
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Arterial Spin Labeling Perfusion of the Brain: Emerging Clinical Applications
Haller, S., Zaharchuk, G., Thomas, D. L., Lovblad, K.-O., Barkhof, F., & Golay, X. (2016) · Radiology · doi:10.1148/radiol.2016150789 · Cited by 514
EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3
Guedj, E., Varrone, A., Boellaard, R., Albert, N. L., Barthel, H., van Berckel, B., Brendel, M., Cecchin, D., Ekmekcioglu, O., Garibotto, V., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05603-w · Cited by 300
Croteau, E., Castellano, C. A., Fortier, M., Bocti, C., Fulop, T., Paquet, N., & Cunnane, S. C. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2017.07.004 · Cited by 258
Imaging biomarkers in neurodegeneration: current and future practices
Young, P. N. E., Estarellas, M., Coomans, E., Srikrishna, M., Beaumont, H., Maass, A., Venkataraman, A. V., Lissaman, R., Jiménez, D., Betts, M. J., et al. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00612-7 · Cited by 225
Metadata
- Authors
- Brown, R. K. J., Bohnen, N. I., Wong, K. K., Minoshima, S., & Frey, K. A.
- Affiliations
- University of Washington (US)
- University of Michigan (US)
- Venue
- RadioGraphics
- Published
- 2014-05
- Volume
- 34
- Issue
- 3
- Pages
- 684-701
- ISSN
- 0271-5333 (ISSN-L)
- 1527-1323
- OpenAlex
- W2141562510
- Cited by
- 256
- References
- 76
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 24 · 2023: 22 · 2022: 30 · 2021: 27 · 2020: 28 · 2019: 22 · 2018: 24 · 2017: 20 · 2016: 18 · 2015: 7 · 2014: 1
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Radiographics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- dementia, FDG-PET, FDG metabolism, Alzheimer's disease, neurodegenerative diseases, imaging biomarkers, early diagnosis, image artifacts, computer-aided diagnosis, visual interpretation, comorbid depression
- MeSH terms
- Brain, Dementia, Diagnosis, Differential, Humans, Image Processing, Computer-Assisted, Tissue Distribution, Artifacts, Radiopharmaceuticals, Neurodegenerative Diseases, Fluorodeoxyglucose F18, Early Diagnosis, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.